Holen Sie sich die Stockscreener-App
14.12
2.54%
0.35
Handel nachbörslich:
14.12
Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten
Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Liquidia Technologies (LQDA) - The Globe and Mail
H.C. Wainwright reiterates Jade Biosciences stock rating at buy - Investing.com India
Jade Biosciences Announces Preclinical Data C - Moomoo
Wedbush reiterates Jade Biosciences stock rating on preclinical data By Investing.com - Investing.com Canada
Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in DermatomyositisSlideshow - Seeking Alpha
Stifel reiterates Jade Biosciences stock rating on drug data By Investing.com - Investing.com Nigeria
Jade Biosciences reports preclinical data for dermatomyositis drug - Investing.com
Jade Biosciences reports preclinical data for dermatomyositis drug By Investing.com - Investing.com South Africa
Jade Biosciences advances JADE301 toward Phase 1 trial - TipRanks
Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026 - TradingView
Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026 - Yahoo Finance
Jade Biosciences at stifel 2026 virtual immunology and inflammation forum: pipeline push - Investing.com Canada
JBIO: JADE101 leads a robust pipeline with best-in-class data and rapid path to market in IgA nephropathy - TradingView
Jade Biosciences at citigroup summit: fast-track bet on igan By Investing.com - Investing.com India
Jade Biosciences at Wells Fargo conference: pipeline bets on JADE 101 By Investing.com - Investing.com South Africa
Jade Biosciences at Wells Fargo conference: pipeline bets on JADE 101 - Investing.com
Jade Biosciences Company Profile & Introduction - moomoo.com
JADE BIOSCIENCES, INC. : CLEAR STREET RAISES TARGET PRICE TO $48 FROM $25 - moomoo.com
symbol__ Stock Quote Price and Forecast - CNN
Clear Street Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $48 - moomoo.com
LifeSci Capital Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $42 - Moomoo
Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance
Jade Biosciences (JBIO) Slips 1.6% as Shares Test Key Support at $19.97Median Line - dars.gov.et
Jade (JBIO) Financial Update: The Bottom-Line Figure Trails Its Comparison in the Latest Session; Investor Response: Shares End With Little Net Change at the CloseEarnings Season Outlook - dars.gov.et
Bio Ionic Partners with Ulta Beauty on Limited Edition Jade Dream Collection - Yahoo Finance
Jade Biosciences (NASDAQ:JBIO) Shares Gap UpWhat's Next? - MarketBeat
Jade Biosciences advances JADE101 for IgAN with promising Phase 1 results and Phase 2 data due in 2027 - Pluang
Jade Biosciences: Duration Is The Real Product (NASDAQ:JBIO) - Seeking Alpha
Jade Biosciences (JBIO) Stock Analysis Report | Financials & Insights - Benzinga España
H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $55 - Moomoo
Stifel Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $40 - Moomoo
HC Wainwright Analysts Increase Earnings Estimates for JBIO - MarketBeat
Jade Biosciences (JBIO) Shares Just Moved, So What Is Going On? - Sahm
Jade Biosciences (JBIO) Advances 2.4% to $22.89 as Buyers Defend Key Support ZoneFlat Correction - vinanet.vn
Renaissance Technologies LLC Boosts Holdings in Jade Biosciences, Inc. $JBIO - MarketBeat
Jefferies Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $48 - Moomoo
Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX) - theglobeandmail.com
Wedbush Maintains Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $47 - Moomoo
A Quick Look at Today's Ratings for Jade Biosciences(JBIO.US), With a Forecast Between $42 to $77 - Moomoo
Jade Biosciences Is Maintained at Buy by BTIG - Moomoo
Jade Biosciences (NASDAQ:JBIO) Given New $77.00 Price Target at BTIG Research - MarketBeat
Jade Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
JBIO Q1 2026 Earnings: Wider Loss Highlights Clinical-Stage Investment CycleEarnings Growth Analysis - careplusvn.com
JBIO SWOT Analysis: Financial Challenges and Development Opportu - GuruFocus
Jade Biosciences, Inc. Stock 12‑Month Price Target Raised to $46.44, Implies 111% Upside - TradingView
Wedbush raises Jade Biosciences price target on pipeline progress By Investing.com - Investing.com Australia
Wedbush raises Jade Biosciences price target on pipeline progress - Investing.com
Jade Biosciences Releases Q2 2026 Financial Results - AlphaStreet
Jade Biosciences Announces Q2 2026 Financial Results Highlighting Increased R&D and Asset Growth - Kalkine Media
Jade Biosciences Q2 Results: EPS Misses Estimate, Losses Widen - scanx.trade
Jade Biosciences' Q2 Loss Narrows - marketscreener.com
Earnings Flash (JBIO) Jade Biosciences Posts Q2 Loss $0.76 a Share, vs. FactSet Est of $0.63 Loss - marketscreener.com
Jade Biosciences reports Q2 net loss $55.8M, cash $461.2M; advances JADE101 to Phase 2/3 - TradingView
Jade Biosciences (NASDAQ: JBIO) boosts cash to $461M while loss widens - Stock Titan
Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Jade Biosciences reports $55.8 million Q2 net loss - Quiver Quantitative
Jade Biosciences Q2 net loss widens as costs rise - TradingView
Jade Biosciences Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):